Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study-Reference-Cited by-同舟云学术

Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study

Published:2011-08 Issue:8 Volume:9 Page:1664-1666
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:

Author:

FONTANA P.,JAMES R.,BARAZER I.,BERDAGUÉ P.,SCHVED J.-F.,REBSAMEN M.,VUILLEUMIER N.,RENY J.-L.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1538-7836.2011.04409.x/fullpdf

Reference17 articles.

1. Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis;Combescure;J Thromb Haemost,2009

2. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite;Kazui;Drug Metab Dispos,2010

3. Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects;Hulot;Blood,2006

4. Influence of CYP2C19 and CYP3A4 gene polymorphisms on clopidogrel responsiveness in healthy subjects;Fontana;J Thromb Haemost,2007

5. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis;Mega;JAMA,2010

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients?;Genes;2024-05-10

2. The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases;International Journal of Molecular Sciences;2021-02-21

3. Impact of selected genetic factors on clopidogrel inactive metabolite level and antiplatelet response in patients after percutaneous coronary intervention;Pharmacological Reports;2020-12-03

4. Platelet Function Test Use for Patients with Coronary Artery Disease in the Early 2020s;Journal of Clinical Medicine;2020-01-10

5. The impact of cytochrome 450 and Paraoxonase polymorphisms on clopidogrel resistance and major adverse cardiac events in coronary heart disease patients after percutaneous coronary intervention;BMC Pharmacology and Toxicology;2020-01-03